Smruthi Organics Limited

SMRUTHIORG6

INE172E01011

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 05:06:11 2024-06-03 am EDT			5-day change	1st Jan Change
168.5 ^INR	-0.30%		-1.75%	-2.88%

May. 06	Smruthi Organics Limited Announces Dividend for the Fiscal Year 2023-2024	CI
May. 06	Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Smruthi Organics Limited Approves Appointment of K. R. Dhole as an Independent Director

September 29, 2014 at 01:21 am EDT

Smruthi Organics Limited at its AGM held on September 27, 2014, approved the appointment of Mr. K. R. Dhole as an independent director of the company to hold the office for five years from this AGM.

Latest news about Smruthi Organics Limited

Smruthi Organics Limited Announces Dividend for the Fiscal Year 2023-2024	May. 06	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 06	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 03	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Smruthi Organics Limited Approves Dividend for the Year Ended 31 March 2023	23-08-05	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-05	CI
Smruthi Organics Limited Proposes Dividend for the Year Ended 31St March, 2023	23-07-12	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-20	CI
Smruthi Organics Limited Announces Dividend for the Fiscal Year 2022-2023	23-05-20	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Smruthi Organics Limited Approves the Dividend for the Year Ended March 31, 2022	22-08-08	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-06	CI
Smruthi Organics Limited Recommends Dividend	22-05-28	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-28	CI
Smruthi Organics Limited Approves Board Changes	22-02-12	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-12	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-13	CI
Smruthi Organics' : Net Profit Slides in Fiscal Q1	21-07-16	MT
Smruthi Organics Limited Declares Dividend for the Year Ended 31 March 2021	21-07-16	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-16	CI
Smruthi Organics Limited Recommends Dividend, Payable on or Before August 14, 2021	21-06-09	CI
Smruthi Organics Limited Recommends Dividend for the Year Ended March 31, 2021	21-04-23	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-04-23	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-01-16	CI

Chart Smruthi Organics Limited

Duration

Period

More charts

Smruthi Organics Limited is an India-based active pharmaceutical ingredients (API) manufacturer serving pharmaceutical companies. The Companyâs segments include Bulk Drugs and Drugs Intermediates and Formulation. It manufactures API products in the anti-diabetic, anti-hypertension and anti-infectives therapeutic categories. Its products include Amlodipine Besilate, Losartan Potassium, Telmisartan, Metformin HCL, S-Amlodipine Besilate, S-Amlodipine Malelate, Valsartan, Vildagliptin, Teneligliptin, Ciprofloxacin HCL, Diloxanide Furoate, Norfloxacin, Pefloxacin Mesylate, Ticagrelor, and others. It caters to both the Indian domestic as well as the rest of the world (ROW) markets, with clients spanning Asia, the Americas, and Africa. The Company has two manufacturing facilities in Solapur, India. The API facility is spread across 22-acre land.

Sector

Pharmaceuticals

Calendar

2024-11-07 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SMRUTHI ORGANICS LIMITED	-2.88%	23.18M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.12%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.56%	22.34B
SANDOZ GROUP AG	+15.93%	15.25B
CIPLA LIMITED	+16.11%	14B
ZYDUS LIFESCIENCES LIMITED	+49.83%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-10.77%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B